Recombinant Enzymes for IVT

About Cocoon Bioscience

Cocoon Bioscience is a private, Madrid-based biotech leveraging a proprietary insect-based expression system, CrisBio®, for recombinant protein production. The platform uses Trichoplusia ni pupae as natural bioreactors, offering advantages in cost, scalability, and the ability to produce complex proteins with proper folding and post-translational modifications. While currently focused on providing enzymes and custom development services, the technology presents a significant platform opportunity for biologics manufacturing across life sciences, positioning the company as an innovative CDMO-like player in the biologics and microbiome sectors.